Skulskii I A, Manninen V
Acta Physiol Scand. 1984 Mar;120(3):329-32. doi: 10.1111/j.1748-1716.1984.tb07391.x.
Both propranolol and the electron donors ascorbate plus phenazine methosulfate increase the K+-permeability of the red blood cell membrane. The present investigation examined whether these effects were additive. Contrary to expectations, propranolol added after electron donors sharply inhibited the K+ (86Rb) efflux induced by such donors, without forming new K4 channels analogous to those induced by propranolol in intact red blood cells. The inhibitory effect of propranolol may be due to generalized disturbances of membrane structures necessary for the functioning of the K+ channels organized in the presence of reducing agents. In contrast, the electron donors added after propranolol caused a further stimulation of the 86Rb loss from the propranolol-treated red cells. The combined effect of these drugs therefore depends on the order of their addition. The possible mechanism of their interaction is briefly discussed.
普萘洛尔以及电子供体抗坏血酸加吩嗪硫酸甲酯均可增加红细胞膜的钾通透性。本研究检测了这些效应是否具有相加性。与预期相反,在电子供体之后加入普萘洛尔会显著抑制此类供体诱导的钾(⁸⁶Rb)外流,且不会形成类似于普萘洛尔在完整红细胞中诱导产生的新钾通道。普萘洛尔的抑制作用可能是由于在还原剂存在的情况下组织钾通道功能所需的膜结构发生了普遍紊乱。相比之下,在普萘洛尔之后加入电子供体可进一步刺激经普萘洛尔处理的红细胞中⁸⁶Rb的流失。因此,这些药物的联合效应取决于它们添加的顺序。文中简要讨论了它们相互作用的可能机制。